Which androgen replacement therapy for women?

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  1998-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1210/JCEM.83.11.5280PMID 9814469
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Androgens and the Postmenopausal Woman

  2000cited by this paper
• Androgens and the menopause; a study of 40–60‐year‐old women

  1996cited by this paper
• Pharmacokinetics and pharmacodynamics of subcutaneous testosterone implants in hypogonadal men

  1996cited by this paper
• Clinical review 82: Androgens and the postmenopausal woman.

  1996cited by this paper
• An audit of oestradiol levels and implant frequency in women undergoing subcutaneous implant therapy

  1995cited by this paper
• Twenty-four-hour mean plasma testosterone concentration declines with age in normal premenopausal women.

  1995cited by this paper
• Exogenous androgens in postmenopausal women.

  1995cited by this paper
• A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density.

  1995cited by this paper
• Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality.

  1995influential reference
• The endocrinology of the menopausal transition: a cross-sectional study of a population-based sample.

  1995cited by this paper
• The climacteric ovary as a functional gonadotropin-driven androgen-producing gland.

  1994cited by this paper
• Oral testosterone undecanoate in the management of delayed puberty in boys: pharmacokinetics and effects on sexual maturation and growth.

  1992cited by this paper
• Women and Men: New Perspectives on Gender Differences

  1991cited by this paper
• Comparative pharmacokinetics of androgen preparations: Application of computer analysis and simulation

  1990cited by this paper
• Pharmacokinetics and pharmacodynamics of testosterone pellets in man.

  1990cited by this paper
• Affective changes with estrogen and androgen replacement therapy in surgically menopausal women.

  1988cited by this paper
• The role of androgen in the maintenance of sexual functioning in oophorectomized women.

  1987cited by this paper
• Effect of combined implants of oestradiol and testosterone on libido in postmenopausal women.

  1987cited by this paper
• Steroid and gonadotropin levels in women during the peri-menopausal years.

  1986cited by this paper
• Adrenal and gonadal androgen secretion in normal females.

  1986cited by this paper
• Differential symptom response to parenteral estrogen and/or androgen administration in the surgical menopause.

  1985cited by this paper
• WHICH TESTOSTERONE REPLACEMENT THERAPY?

  1984cited by this paper
• HORMONAL PROFILES IN POSTMENOPAUSAL WOMEN AFTER THERAPY WITH SUBCUTANEOUS IMPLANTS

  1981cited by this paper
• Sex differences in the twenty-four-hour mean plasma concentrations of dehydroisoandrosterone (DHA) and dehydroisoandrosterone sulfate (DHAS) and the DHA to DHAS ratio in normal adults.

  1980cited by this paper
• The hormonal activity of the postmenopausal ovary.

  1976cited by this paper
• Effect of oophorectomy on circulating testosterone and androstenedione levels in patients with endometrial cancer.

  1974cited by this paper
• Metabolism of testosterone and androstenedione in normal and ovariectomized women.

  1969cited by this paper

• Testosterone Pellets in Women: Revisiting Safety and Clinical Outcomes

  2025influential citation
• Compounded hormonal pellets: a critical review of current evidence and risks

  2025cites this paper
• Long-term testosterone pellet insertion in women with low libido shows no evidence of erythrocytosis and a minimal side effect profile

  2025cites this paper
• The clinical management of testosterone replacement therapy in postmenopausal women with hypoactive sexual desire disorder: a review

  2022cites this paper
• [Efficacy and safety of testosterone in the treatment of hypoactive sexual desire in women: what does the evidence say?]

  2022cites this paper
• International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women

  2021cites this paper
• International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women

  2021cites this paper
• International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women.

  2021influential citation
• The Follicular Output Rate (FORT) as a method to evaluate transdermal testosterone efficacy in poor responders

  2020cites this paper
• Comparison of GnRH agonist versus luteal estradiol GnRH antagonist protocol using transdermal testosterone in poor responders

  2019cites this paper
• The International Society for the Study of Women's Sexual Health Process of Care for Management of Hypoactive Sexual Desire Disorder in Women

  2018cites this paper
• An update on the pharmacological management of female sexual dysfunction

  2012cites this paper
• Androgen replacement therapy in women

  2012cites this paper
• Women's sexual desire and arousal disorders.

  2010cites this paper
• Transdermal menopausal hormone therapy: delivery through skin changes the rules

  2010influential citation
• Hypoactive sexual desire disorder

  2010cites this paper
• Transdermal testosterone may improve ovarian response to gonadotrophins in low-responder IVF patients: a randomized, clinical trial.

  2009cites this paper
• Testosterone therapy for sexual dysfunction in postmenopausal women

  2008cites this paper
• NADOMESTNO ZDRAVLJENJE Z ANDROGENI V POMENOPAVZI ANDROGEN REPLACEMENT THERAPY IN POSTMENOPAUSE

  2008cites this paper
• Prolonged effects of intra-nasally administered testosterone on proceptive behavior in female capuchin monkeys (Cebus apella).

  2007cites this paper
• Androgen replacement in women.

  2007cites this paper
• Androgen therapy in women.

  2006cites this paper
• Effects of treatment with testosterone alone or in combination with estrogen on insulin sensitivity in postmenopausal women.

  2006cites this paper
• Pretreatment with transdermal testosterone may improve ovarian response to gonadotrophins in poor-responder IVF patients with normal basal concentrations of FSH.

  2006cites this paper
• cartas ao editor Resposta à Carta: Terapia Hormonal da Menopausa Baseada em Evidências

  2006cites this paper
• The role of androgens in female sexual dysfunction

  2006cites this paper
• Insuficiencia androgenica na mulher e potenciais riscos da reposicao terapeutica

  2005cites this paper
• [Female androgen insufficiency and potential risks of therapeutic replacement].

  2005cites this paper
• Síndrome de insuficiencia androgénica Síndrome de insuficiencia androgénica Síndrome de insuficiencia androgénica Síndrome de insuficiencia androgénica Síndrome de insuficiencia androgénica

  2005cites this paper
• Testosterone for peri- and postmenopausal women.

  2005cites this paper
• New facets of androgen replacement therapy during childhood and adolescence

  2005cites this paper
• Induction of Testosterone Metabolism by Esomeprazole in aCYP2C19*2 Heterozygote

  2004cites this paper
• Androgen insufficiency in women: diagnostic and therapeutic implications.

  2004cites this paper
• DEFICIENCIA DE ANDRÓGENOS EN LA MUJER Conferencia presentada en el VII Curso de Actualización en Endocrinología, Mérida, Noviembre 2003.

  2004cites this paper
• Androgen insufficiency in women: diagnostic and therapeutic implications

  2004cites this paper
• The role of androgen therapy.

  2003cites this paper
• [Androgens, well-being and libido in women].

  2003cites this paper
• Management of the androgen-deficient woman.

  2003cites this paper
• Rationale for Treating Hypoandrogenism in Women

  2003cites this paper
• Pharmacokinetic Study in Women of Three Different Doses of a New Formulation of Oral Testosterone Undecanoate, Andriol Testocaps

  2003influential citation
• The Androgen Deficiency Syndrome in Women

  2002cites this paper
• The role of androgen therapy.

  2002cites this paper
• [DHEA: an unknown star].

  2002cites this paper
• The circalunar cycle of salivary testosterone and the visual-spatial performance.

  2002cites this paper
• DHEA : célèbre et méconnue

  2002cites this paper
• Skeletal muscle dysfunction in chronic obstructive pulmonary disease.

  2001cites this paper
• Ménopause et fonction sexuelle

  2001cites this paper
• Pharmacokinetics of testosterone after percutaneous gel or buccal administration.

  2001cites this paper
• Menopause and Sexual Function

  2001cites this paper
• Androgens in Postmenopausal Women: Production, Possible Role, and Replacement Options

  2001cites this paper
• Decreased Testosterone in Regularly Menstruating Women with Decreased Libido: A Clinical Observation

  2001cites this paper
• Potential Therapeutic Effects of Prescribed and Over-the-Counter Androgens in Women

  2001cites this paper
• Androgen Deficiency in Women

  2001cites this paper
• Androgen deficiency in women.

  2001cites this paper
• Serum and urinary prostate-specific antigen and urinary human glandular kallikrein concentrations are significantly increased after testosterone administration in female-to-male transsexuals.

  2000cites this paper
• COMMENTARY Androgen Replacement in Women: A Commentary

  1999influential citation
• The use of androgens in menopause.

  1999cites this paper
• Androgen replacement in women: a commentary.

  1999cites this paper
• Androgen treatment in women

  1999cites this paper